Literature DB >> 16843446

A561C polymorphism of E-selectin is associated with ischemic cerebrovascular disease in the Japanese population without diabetes mellitus and hypercholesterolemia.

Hidenori Hattori1, Hideki Sato, Daisuke Ito, Norio Tanahashi, Mitsuru Murata, Ikuo Saito, Kiyoaki Watanabe, Norihiro Suzuki.   

Abstract

E-selectin, which is a member of the selectin superfamily of adhesion molecules, contributes to the leukocyte-endothelial cell attachments and is involved in the pathogenesis of thrombovascular diseases as a consequence. We investigated the A561C mutation in the E-selectin gene in 235 Japanese patients with ischemic cerebrovascular disease (CVD) and 301 age- and sex-matched healthy controls. Excluding the subjects with diabetes mellitus and hypercholesterolemia, the AC genotype frequencies of patients with ischemic CVD were higher than those of controls: 12.7% vs. 5.8% (P=0.04). Our results show that E-selectin gene polymorphisms represent an increased risk for ischemic CVD in the Japanese population without diabetes mellitus and hypercholesterolemia.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16843446     DOI: 10.1016/j.brainres.2006.06.023

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  3 in total

1.  Role of ICAM-1 and E-selectin gene polymorphisms in pathogenesis of PAOD in Egyptian patients.

Authors:  Olfat Shaker; Amr Zahra; Ahmed Sayed; Ayman Refaat; Zakaria El-Khaiat; Gehan Hegazy; Khaled El-Hindawi; Mohamed Ay-El Deen
Journal:  Vasc Health Risk Manag       Date:  2010-02-04

2.  Genetic variations in E-selectin and ICAM-1: relation to atherosclerosis.

Authors:  Tarek Motawi; Olfat Shaker; Noha Taha; Marwa Abdel Raheem
Journal:  Med Sci Monit       Date:  2012-06

3.  Low frequency haplotypes of E-selectin polymorphisms G2692A and C1901T give increased protection from coronary artery disease.

Authors:  Jarosław Gorący; Iwona Gorący; Mariusz Kaczmarczyk; Miłosz Parczewski; Mirosław Brykczyński; Jeremy Clark; Krzysztof Safranow; Andrzej Ciechanowicz
Journal:  Med Sci Monit       Date:  2011-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.